The A4 study: beta-amyloid and cognition in 4432 cognitively unimpaired adults
Insel, P. S., Donohue, M. C., Sperling, R., Hansson, O., & Mattsson‐Carlgren, N. (2020). Ann Clin Transl Neurol. 2020 May; 7(5): 776–785. READ MORE
Association of Factors With Elevated Amyloid Burden in Clinically Normal Older Individuals
Sperling, R. A., Donohue, M. C., Raman, R., Sun, C. K., Yaari, R., Holdridge, K., … & Aisen, P. S. JAMA Neurol. 2020 Jun; 77(6): 1–11. READ MORE
Effectiveness of online education for recruitment to an Alzheimer's disease prevention clinical trial
Saif N, Berkowitz C, Tripathi S, et al. Alzheimer’s & dementia : translational research & clinical interventions; Alzheimers Dement (N Y). 2020; 6(1): e12006. READ MORE
The effectiveness of small-group community-based information sessions on clinical trial recruitment for secondary prevention of Alzheimer's disease
Tarrant SD, Bardach SH, Bates K, et al. Alzheimer Dis Assoc Disord. 2017;31(2):141-145. READ MORE
Development of a process to disclose amyloid imaging results to cognitively normal older adult research participants
Off
Harkins, K., Sankar, P., Sperling, R., Grill, J. D., Green, R. C., Johnson, K. A., … & Karlawish, J. Alzheimers Res Ther. 2015; 7(1): 26. READ MORE
The Preclinical Alzheimer Cognitive Composite: Measuring Amyloid-Related Decline
Donohue MC, Sperling RA, Salmon DP, et al. JAMA Neurol. 2014 Aug; 71(8): 961–970. READ MORE
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Sperling RA, Aisen PS, Beckett LA, et al. Alzheimers Dement. 2011;7(3):280-292. READ MORE
